Navigation Links
eSoles Custom Footbeds Sponsors OUCH Pro Cycling Team in America's Largest Road Cycling Race
Date:2/11/2009

SCOTTSDALE, Ariz., Feb. 11 /PRNewswire/ -- eSoles(R) Custom Footbeds, the world's leading authority in the science and development of semi-custom and custom footbeds, today announced that it is an official sponsor of the OUCH(R) Professional Cycling Team presented by Maxxis in the 2009 Amgen(R) Tour of California road cycling race, which takes place over the course of 750 miles from Sacramento to Escondido, February 14 - 22, 2009.

eSoles performed foot scans on the team, including members Floyd Landis, Rory Sutherland, and Tim Johnson, using the company's new 3D TruCapture(R) Kiosk Scanning System, at the team's training camp in Temecula, California. Team members are outfitted with eSoles' eFit(TM) semi-customized cycling footbeds, which place the cyclists' feet in proper alignment, helping them apply optimum power and reducing back and joint stress during the upcoming race session.

"Bike riders' contact points with a bicycle are critical in delivering maximum power, while maintaining comfort, and that is why we sought out eSoles as a key partner to the OUCH Professional Cycling Team," said Thierry Attias, president of Momentum Sports Group, LLC, which owns and operates the team. "No two pairs of feet are the same, so why should performance and comfort be compromised with uniformly built shoes? eSoles helps us win by making certain our athletes deliver 100% of their power output to the bike while staying comfortable."

"The decision by the OUCH Professional Cycling Team to use eSoles is proof that our footbeds are increasingly sought-after in the professional cycling world as a true breakthrough in the science of sports technology," said Glen Hinshaw, co-founder and CEO of eSoles. "eSoles is pleased to be providing the OUCH team with footbeds that will improve their performance and comfort during their first major competition of 2009."

About eSoles Custom Footbeds:

eSoles, LLC, based in Scottsdale, Arizona, has the only direct, non-weight bearing 3D TruCapture imaging technology for custom and semi-custom insole production. eSoles makes custom insoles for cycling, running, walking, skiing, hiking, golf and dress shoes, and can currently be found in the footwear of world-class athletes and Olympians across various sports. eSoles custom footbeds are currently available through authorized dealers throughout the country and at eSoles' corporate offices in Scottsdale, Arizona. For more information on eSoles and a list of dealers, go to http://www.esoles.com.

eSoles(R), eFit(TM) and 3D TruCapture(R) are registered trademarks of eSoles, LLC. All other trademarks or registered trademarks are property of their respective organizations.


'/>"/>
SOURCE eSoles
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
2. Customized virus kills brain tumor stem cells that drive lethal cancer
3. Whole Foods Market(R) Donates $25,000, for Midwest Farmers - Hoping to Match an Additional $10,000, via Customer Donations
4. Blue Cross Blue Shield of Michigan Offers New Approach to Customer Group Wellness
5. Roy Jakobs Appointed Elsevier Managing Director, A&G Sales and Customer Marketing
6. J.D. Power and Associates Reports: CIGNA HealthCare Recognized for Call Center Customer Satisfaction Excellence For a Second Consecutive Year
7. Nucletron Announces Management Buy-Out to More Effectively Meet the Demands of Its Customers and the Radiation Therapy Community
8. Texas Aviation Services: Over 20 Years of Creating Flying Emergency Rooms for Airborne EMS Customers in US and Latin America
9. LodgeNet Deploys Customized Kid Friendly Solution With Childrens Hospital of Pittsburgh of UPMC
10. New Technology at Unitrin Direct Gives Customers an Alternative to Waiting
11. Verizon Introduces Broadband Video Call Center Link for Deaf or Hard-of-Hearing Customers in Mid-Atlantic Region
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... CARTERSVILLE, Georgia (PRWEB) , ... March 28, 2017 ... ... analyst to its award-winning team. Ruel Williamson brings his extensive knowledge of appraisals, ... been a leader in the real estate valuation industry for more than 40 ...
(Date:3/28/2017)... ... March 29, 2017 , ... Dr. Isabella Wentz, PharmD, FASCP, one ... video series titled The Thyroid Secret. Dr. Wentz talked about journey and research recently ... fact that medication IS NOT the only solution to deal with thyroid disease. ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... and by physicians, announced today the launch of a free, public-facing tool for ... Cost Analyzer (VCA) was developed to provide comparative information to patients, providers, insurers ...
(Date:3/28/2017)... , ... March 28, 2017 , ... Usually, the impending ... daily wardrobe. However, for those self-conscious about a double chin, this means more anxiety ... ideal solution. , “For most people, a double chin is undesirable,” Dr. Goldman ...
(Date:3/28/2017)... ... March 28, 2017 , ... Qualidigm , the ... headquarters to a new, more expansive office space in order to accommodate its ... a distressed office building in Wethersfield, Conn. located at 936 Silas Deane Highway ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... REDWOOD CITY, Calif. , March 28, 2017 ... pharmaceutical company focused on the development and commercialization ... acute pain, announced that the European Medicines Agency ... (sufentanil sublingual tablet, 30 mcg) Marketing Authorisation Application ... review of the MAA is underway. The MAA ...
(Date:3/28/2017)... , March 28, 2017  Medeon Biodesign, Inc., ... company, is pleased to announce that the Company ... of Panther Orthopedics, Inc., a San ... fixation solutions for orthopedic extremity applications.  ... expand rapidly, primarily due to procedure volume growth, ...
(Date:3/27/2017)... 2017 Therapix Biosciences Ltd. ... in the development of cannabinoid-based drugs, today announced ... the United States of 2,000,000 ... ordinary shares of the Company, at a price ... granted the underwriters a 45-day over-allotment option to ...
Breaking Medicine Technology: